These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31715357)

  • 21. Development and Evaluation of Novel Polymeric Nanoparticles of Brimonidine Tartrate.
    Singh KH; Shinde UA
    Curr Drug Deliv; 2010 Jul; 7(3):244-51. PubMed ID: 20497099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and characterization of loratadine nanosuspension prepared by ultrasonic-assisted precipitation.
    Alshweiat A; Katona G; Csóka I; Ambrus R
    Eur J Pharm Sci; 2018 Sep; 122():94-104. PubMed ID: 29908301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic approach for the formulation and optimization of atorvastatin loaded solid lipid NANOAPARTICLES using response surface methodology.
    Sarangi B; Jana U; Sahoo J; Mohanta GP; Manna PK
    Biomed Microdevices; 2018 Jun; 20(3):53. PubMed ID: 29946758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface engineered and ligand anchored nanobioconjugate: an effective therapeutic approach for oral insulin delivery in experimental diabetic rats.
    Sharma R; Gupta U; Garg NK; Tyagi RK; Jain NK
    Colloids Surf B Biointerfaces; 2015 Mar; 127():172-81. PubMed ID: 25679489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acyclovir Solid Lipid Nanoparticles for Skin Drug Delivery: Fabrication, Characterization and In vitro Study.
    Bhupinder K; Newton MJ
    Recent Pat Drug Deliv Formul; 2017; 11(2):132-146. PubMed ID: 28124592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Facts and evidences on the lyophilization of polymeric nanoparticles for drug delivery.
    Fonte P; Reis S; Sarmento B
    J Control Release; 2016 Mar; 225():75-86. PubMed ID: 26805517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Annealing as a tool for the optimization of lyophilization and ensuring of the stability of protein-loaded PLGA nanoparticles.
    Fonte P; Lino PR; Seabra V; Almeida AJ; Reis S; Sarmento B
    Int J Pharm; 2016 Apr; 503(1-2):163-73. PubMed ID: 26972381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment.
    Wong CY; Al-Salami H; Dass CR
    J Control Release; 2017 Oct; 264():247-275. PubMed ID: 28887133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple Lipid Nanoparticles (MLN), a New Generation of Lipid Nanoparticles for Drug Delivery Systems: Lamivudine-MLN Experimental Design.
    Cavalcanti SMT; Nunes C; Lima SAC; Soares-Sobrinho JL; Reis S
    Pharm Res; 2017 Jun; 34(6):1204-1216. PubMed ID: 28315084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
    Derakhshandeh K; Erfan M; Dadashzadeh S
    Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of freeze-drying, cryoprotectants and storage conditions on the stability of secondary structure of insulin-loaded solid lipid nanoparticles.
    Soares S; Fonte P; Costa A; Andrade J; Seabra V; Ferreira D; Reis S; Sarmento B
    Int J Pharm; 2013 Nov; 456(2):370-81. PubMed ID: 24036086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S; Reddy VA; Arora S; Patel K
    Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A potential nanoparticle-loaded in situ gel for enhanced and sustained ophthalmic delivery of dexamethasone.
    Wen Y; Ban J; Mo Z; Zhang Y; An P; Liu L; Xie Q; Du Y; Xie B; Zhan X; Tan L; Chen Y; Lu Z
    Nanotechnology; 2018 Oct; 29(42):425101. PubMed ID: 30074486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pH-sensitive nanoparticles for improved oral delivery of dapsone: risk assessment, design, optimization and characterization.
    Chaves LL; Costa Lima SA; Vieira AC; Barreiros L; Segundo MA; Ferreira D; Sarmento B; Reis S
    Nanomedicine (Lond); 2017 Aug; 12(16):1975-1990. PubMed ID: 28745104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fabrication of long-acting insulin formulation based on poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles: preparation, optimization, characterization, and in vitro evaluation.
    Bayrami S; Esmaili Z; SeyedAlinaghi S; Jamali Moghadam SR; Bayrami S; Akbari Javar H; Rafiee Tehrani M; Dorkoosh FA
    Pharm Dev Technol; 2019 Feb; 24(2):176-188. PubMed ID: 29557733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design for optimization of nanoparticles integrating biomaterials for orally dosed insulin.
    Woitiski CB; Veiga F; Ribeiro A; Neufeld R
    Eur J Pharm Biopharm; 2009 Sep; 73(1):25-33. PubMed ID: 19508892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of Box-Behnken experimental design for the formulation and optimisation of selenomethionine-loaded chitosan nanoparticles coated with zein for oral delivery.
    Vozza G; Danish M; Byrne HJ; Frías JM; Ryan SM
    Int J Pharm; 2018 Nov; 551(1-2):257-269. PubMed ID: 30153488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
    Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
    AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.